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ABSTRACT 
 
Innovation and technology are considered as a subject of success and achievement to the firm. The 
comparative study represents an essential procedure to identify the innovation and technological 
capabilities of major players involved in the bioinformatics related inventions. The aim of the research 
is to map out the top firms and identify their strategically important technologies. In view of this, the 
comparative analysis of major firms in bioinformatics industry is carried out using patent information. 
Herein the top three assignees are considered and based on this further analysis is performed. The top 
companies’ trend suggests that Thermo Fisher Scientific Inc. is the major player in bioinformatics 
research. Thus, we have tried to develop an overview on their patenting trend and important concerned 
areas of research. Also, our results indicate that the application of computational tools is being utilized 
for most of the research areas like the study of genomics and proteomics, sequence categorization and 
their structural prediction. 
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ATOS DE PATENTE PARA ESTUDIO COMPARATIVO: ESTUDIO DE CASO DE ASPIRANTES  
PRINCIPALES EN LA INDUSTRIA DE LA BIOINFORMÁTICA 
 
 
 
RESUMO  
 
La innovación y la tecnología se consideran un tema de éxito y logro para la empresa. El estudio 
comparativo representa un procedimiento esencial para identificar la innovación y las capacidades 
tecnológicas de los principales actores involucrados en las invenciones relacionadas con la 
bioinformática. El objetivo de la investigación es trazar un mapa de las principales firmas e identificar 
sus tecnologías estratégicamente importantes. En vista de esto, el análisis comparativo de las 
principales empresas en la industria de la bioinformática se lleva a cabo utilizando información de 
patentes. Aquí se consideran los tres principales cesionarios y se basa en este análisis adicional. La 
tendencia de las principales compañías sugiere que Thermo Fisher Scientific Inc. es el principal actor en 
la investigación bioinformática. Por lo tanto, hemos tratado de desarrollar una visión general de su 
tendencia de patentamiento y áreas de investigación importantes. Además, nuestros resultados indican 
que la aplicación de herramientas computacionales se está utilizando para la mayoría de las áreas de 
investigación como el estudio de la genómica y la proteómica, la categorización de secuencias y su 
predicción estructural. 
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INTRODUCTION 
 
Various methods of technological 
expansion in bioinformatics research over last 15 
decades has given rise to the interest in 
protecting such creative ideas to uplift the 
research area. The industries which are dominant 
on the bioinformatic sector has delivered 
successful inventions for predicting functions of 
unknown genes and protein, sequence related 
analysis, and mathematical or statistical based 
simulations (Perez-Iratxeta et al., 2007). They 
have also, provided solutions to many diseases to 
the world, wherein scientist and researchers 
work-in-parallel with the vision of the industry 
(Chow et al., 2001). The bioinformatic industry 
has supported the pharmaceutical and 
biotechnological industries to contribute to the 
analysis and management of data obtained from 
genomics and proteomics. Such analytical tools, 
software and hardware products are vitally 
important, especially in the process of drug 
discovery and development. The products are 
highly effective and accurately analyse the data 
generated from high-throughput technologies 
such as DNA microarrays technologies (Chang et 
al., 2004). Thus, the innovation and technology 
are equally important for the growth of an 
industry. The advancement in the research and 
development activity gives rise to the increase in 
technological development and innovations, 
happening in product and process technologies 
(Santos et al., 2015). However, it is advisable to 
perform technology and state-of-art analysis 
before bringing new inventions in productive 
form. The analysis provides a global overview 
regarding the development of certain technology 
and the major companies involved.  
 
INNOVATION AND 
BIOINFORMATICS 
 
The development observed from the last 
so many decades in the bioinformatic sector has 
fascinated industries that mainly belongs to 
biotechnology and pharmaceutical sector (Chang 
et al., 2004). The most commonly noticed shift 
have been from the process of drug discovery to 
in-silico structure based drug design (Choi et al., 
2016). The application of computer technology 
for the management of biological information 
delineates bioinformatics. Wherein the activity of 
biological computing makes various system to 
work efficiently to easily access, manage and 
retrieve biological information. It resolves 
biological problems in the areas of DNA and 
Protein related analysis which includes sequence 
categorization, structural and functional 
prediction, protein interaction studies and 
various modeling pathways (Ouzounis et al., 
2003). Furthermore, the next-generation 
sequencing generates an enormous amount of 
data which requires storing and transforming the 
information into value in new ways (de Brevern et 
al., 2015).  
 
Value of patent information 
 
Patents are indeed unique and essential 
information source holding new technology 
information. They provide an insight into industry 
developments, technology advancement, and 
information about new invention in detail. It is 
considered as a well-categorized technical 
documents updated till date on new and 
innovative technologies. Worldwide, the patent 
document is filed in accordance with the regional 
or national patent system. Wherein the 
information is indexed in standardized form 
uncovering the background and details of the 
invention along with its limitation and 
application. A patent application takes almost 18 
months to get published prior to the date of filing 
and an applicant may use its protection right for 
at most 20 years considered from the date of 
filing. So, there is a time lag in patent procedure 
between the filing and publication of the patent 
application. The patent referred as the techno-
legal document, which assists in defining the 
knife-edge of technological information covering 
innovative product or process, and 
consequentially it reflects the success or failure of 
a company. For this reason, the protection of any 
sort of creative thinking is vital in the form of 
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patents. The time spent on strategy at any 
juncture of a patent intelligence is important for 
the progress and success of revealed technical 
information (Hong et al., 2007). However, the 
patenting trend and information covered within 
the technical documents help in the identification 
of new and emerging competitors’ along with 
their technology development. With the patent 
datasets and information, the competitive 
intelligence of major aspirants can be observed 
(Katila et al., 2000). The comparative analysis of 
various companies denotes the strategically 
important technologies utilised respectively and 
also, identifies if they are with the pace of 
technology (Afuah, 2002). So, this paper covers 
the comparative analysis of the firms’ to develop 
insights on their patenting trends, main focus 
areas of research and shedding a light on their 
strategy to compete with the day-to-day 
technology advancement.  
 
METHOD  
 
In order to achieve the above objective, it 
was required to extract the patent data for which 
an effective search was carried out. The executed 
search strategy was based on technology-based 
keywords, IPC (International Patent 
Classification) and CPC (Cooperative Patent 
Classification) system in relation to bioinformatics 
related invention. The most relevant patent 
applications were retrieved were until December 
2015. As the innovation and technology are 
equally important for the growth of an industry 
[4]. Thus, in this paper, we will examine the 
analogy of top leading players in the 
bioinformatics industry. First, we will observe the 
patenting trend and major aspirants of 
bioinformatics related inventions. Later, we will 
perform the comparison with the major active 
players and explore their advancement and 
development under bioinformatics sector by 
executing correlation between them.  
 
RESULTS AND DISCUSSION 
 
The comparative study for top leading 
companies was performed to provide 
strategically important technologies in 
bioinformatics industry. The analysis will provide 
comparison between the firms by the way of 
gauging their innovation and technological 
capabilities.  
 
Patenting trend 
 
Figure 1 depicts the distribution of patent 
applications filed annually where the patent filing 
year was considered for the analysis. The earliest 
patenting activity was seen in the year 1990s. The 
steady growth and increase in patent trend was 
observed after the year 2002. The pickup of 
patenting activity was recorded in the year 2013 
and onwards, where the number of patent 
applications were maximum. During this period, 
the peak indicated the increase in research 
interest in bioinformatics industry. Also, the 
number of patent applications during the year 
2014 and 2015 is incompletely represented due 
to the procedural time lag in patent filing as 
patent applications are published only after a 
period of 18 months from the date of filing. Also, 
it is worth noting that over the period of last 15 
years there is a continued research and 
innovative growth in the field.
 
Figure 1: Overall Patent Filing Trend. 
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Firm B
Firm C
 
 
Comparative analysis for top 
assignees 
 
The R&D emphasis by competitors and 
their strategies in the specific technological field 
can be interpreted from the companies patenting 
activity. The companies’ patenting activity and 
competitive position are analyzed from the 
retrieved patent datasets. The top three 
applicants are considered in respect of the 
number of patents filed every year. Their patent 
filing activity and technological advancement is 
observed. The parameters used to compare the 
top applicants/assignees development, are 
discussed as below;  
 
Patent share 
 
The number of patents held by assignee 
indicates the dominant players in bioinformatics-
related research and their extent to exploit a 
certain technology. The top three assignees 
represented as Thermo Fisher Scientific Inc. (Firm 
A), Hitachi Ltd. (Firm B) And IBM Corp. (Firm C) 
were considered for further analysis. Figure 2 
reveals the competitive position within the 
bioinformatics industry which denote the share 
of patents held by the top three firms. Firm A, has 
filed the maximum number of patent 
applications. The patent filing activity by Firm A is 
the highest after the year of 2012. The company 
works maximum in genomics, proteomics, and 
sequence related research to provide numerous 
health-related solutions and has become a 
premier leader in life science sector. The success 
behind the growth of a company lies in major 
merger and acquisition with the world’s best 
brand like Applied Biosystems, Life technologies 
Corp, Invitrogen etc.  
 
 Figure 2: Comparison between top applicants 
based on the count of patent filed.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Table 1 represents the count 
distributed among the topmost technologies 
covered in the field of bioinformatics and related 
inventions. Firm A covers the majority of share in 
research area which relates to sequence analysis, 
determining or predicting the function of genes 
and proteins, and utilization of computational 
technologies. Whereas, the patent application 
count of Firm B represents that the sequence 
related analysis and informatics are the majorly 
focused areas. Similarly, Firm C works mainly in 
the same research area as Firm A and Firm B but 
there patent filing was activity observed to be 
significantly less as compared to other two. The 
complete count distribution of patent filing 
application in certain technology indicates that 
Firm A is a clear leader in the bioinformatics 
industry.   
Table 1: List of number of filed patent 
categorised in respect of majorly used IPC class.
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Bi-variate correlation  
 
The Bivariate Pearson Correlation two-
tailed significance test is performed to compare 
the patent filing activity among top three 
companies. The Pearson correlation is capable of 
detecting linear associations between variables 
and it was carried out using PSPP software. The 
data represented in table 1 is used for the 
calculation were majorly utilized technologies 
were distributed. The correlation comes in the 
range of -1 to +1 where the range indicates the 
strength of the relationship. Figure 3 gives all the 
correlation and two-tailed significance value 
among the top three firms. It represents the 
lowest index of correlation for Firm B and Firm C. 
This brings out important facts in respect to 
specific technologies. The correlation between 
the three firms showed that firm C is significantly 
less related and signifies that it is far apart in the 
research area of bioinformatics industry. On the 
other hand, firm A and Firm B are statistically 
closely related which represents that the two 
firms are sharing interests and focus in the similar 
research area.  
 
Figure 3: The bivariate correlation calculated to 
identify the correlation between top 3 applicants 
using PSPP Software
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 
The analysis of patent information 
extracted for the bioinformatic related inventions 
is shedding a light on the topmost innovator 
firms. It reveals the patent filing trend in the 
bioinformatic sector. The increase in trend is 
observed in recent years 2013 and onwards. 
However, the Thermo Fisher Scientific Inc. 
represented as Firm A in the paper, is recorded as 
a top leading patent assignee holding a maximum 
number of patent applications in the 
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corresponding year. Further, the study has shown 
the comparison between the top leading players 
and considered two main parameters for the 
analysis. One is observing the patent held by each 
of them and other is finding the statistical 
relationship based on the various technological 
areas covered under bioinformatics industry. In 
view of mentioned parameters, it has been 
determined that Thermo Fisher Scientific Inc. and 
Hitachi Ltd. are working in the similar research 
areas. It depicts that both the companies 
followed a similar patenting strategy to focus on 
the majorly concerned research technologies like 
functional genomics and proteomics, sequence 
related research, and protein structure 
predictions.  
The assignee analysis suggests the best 
strategically important technologies to the 
industry. Thus, concluding that Thermo Fisher 
Scientific Inc. is an innovator firm overriding in 
the industry providing new and innovative 
technologies which cover processes and 
products. In last five years, they have been 
merging and acquiring the top brands like Applied 
Biosystems, Life technologies Corp, Invitrogen 
etc. So, in technolgy-driven age the innovation 
and creativity holds the success of firm where 
patenting strategy is essential. Alongwith, 
alignment of such IP strategy with the company’s 
objectives and business plan is also important. 
Wherein relevant decisions are made for 
technology exploitation in best possible way 
which leads to the development and success of a 
company.  
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